ISTP, 8025 Lamon Ave. Skokie, Il 60077

Exicure: Nasdaq Uplisting

Exicure (XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs, reported financial results for 2Q 2019 & an update on corporate progress.

2Q 2019 Progress & Recent Developments

Announced important preclinical data supporting development of SNA technology in the central nervous system (CNS)

Expanded Board with experienced biotechnology leaders

AST-008 Phase 1b/2 clinical trial continues to progress—AST-008 is an SNA consisting of toll-like receptor 9 agonists designed for immuno-oncology applications.

Enhanced Financial Resources
• Up-listed from the OTC to the Nasdaq Capital Market.
• Closed oversubscribed underwritten public offering of 31,625,000 shares of common stock
• Insider participation of approximately $2.6 M

“The first half of 2019 continued to bring advancements across our pipeline,” said Dr. David Giljohann, Exicure’s chief executive officer. “We are extremely pleased with the strong progress in both our neurology and oncology franchises, while we simultaneously strengthened our board leadership and balance sheet. Our non-human primate data confirmed our enthusiasm for neurological applications of our SNA platform. Our recent $63.3 million public offering, which closed on August 2, 2019 provides the financial resources to advance these opportunities,” he added.

For the entire announcement, click here.

Comments Off on Exicure: Nasdaq Uplisting News

Read more

2019 International Institute for Nanotechnology

IIN Symposium: Maps, Materials, and Methods for Navigating the Nanoscale World

Thursday, November 14
8:30 a.m. to 6:00 p.m.
Hilton Orrington Hotel, Grand Ballroom
1710 Orrington Avenue
Evanston, IL

Speakers:
Stefan Hell, 2014 Nobel Laureate, Max Planck Institute, Germany
Harry Anderson, Oxford University, England
Julia Greer, California Institute of Technology
David Mooney, Harvard University
The winner of the 2019 Kabiller Prize

Organized by IIN, this popular all-day conference brings together leading national and international researchers to share the latest in nanotechnology discoveries and trends. The Symposium also provides a unique opportunity to encourage interactions and collaborations among the scientists in attendance.

Click here for a link to the IIN page.

Comments Off on 2019 International Institute for Nanotechnology Events, News

Read more

NuMat Technologies Innovations Grant

American small businesses got nearly a $22 million boost from the Energy Department’s Office of Energy Efficiency and Renewable Energy (EERE) Small Business Innovation Research (SBIR) program. Small businesses are receiving Phase 1 Release II grants that demonstrate technical feasibility for innovations during the first phase of their research

NuMat Technologies (NuMat) of Skokie, IL will determine if innovative, high-efficiency filters can be used to remove impurities from hydrogen gas streams. Fuel cell electric vehicles (FCEVs) require high-purity hydrogen fuels that is expensive, and as a result, are preventing widespread adoption of FCEVs. This SBIR seeks to address this problem through the development of low-cost point-of-use filters to purify hydrogen. For more about this grant , click here.

Comments Off on NuMat Technologies Innovations Grant News

Read more